| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |